Biomictra

Biomictra is a South Korean biotechnology company specializing in the development of microbiome-based therapeutics. The company leverages its proprietary Mictra platform to identify and develop microbial-derived extracellular vesicles (EVs) and metabolites for inflammatory and metabolic diseases. Their lead programs focus on treating skin conditions like atopic dermatitis and systemic inflammatory disorders such as inflammatory bowel disease. Biomictra aims to harness the symbiotic relationship between the human microbiome and the immune system to create next-generation biologics. The company is currently advancing its pipeline through pre-clinical validation with a specific focus on the gut-skin axis.